3/7/2013

Recent breakthroughs in drug-resistant tuberculosis, malaria and HIV/AIDS were made possible with federal funding, and cuts to that funding threaten future such breakthroughs, writes Kaitlin Christenson, coalition director of the Global Health Technologies Coalition. "Without question, cuts of this magnitude will severely hamper scientific progress at [NIH and the State Department] to develop new vaccines, drugs, and other health tools against HIV/AIDS, TB, malaria, and neglected tropical infections like Chagas -— diseases that are increasingly affecting American populations," she writes. Upcoming budget negotiations present a prime opportunity to reduce cuts to scientific and public health research and to renew U.S. leadership, she writes.

Related Summaries